RUNNING POINT CAPITAL ADVISORS, LLC Amicus Therapeutics, Inc. Transaction History

RUNNING POINT CAPITAL ADVISORS, LLC portfolio value:

$104,000
portfolio value

RUNNING POINT CAPITAL ADVISORS, LLC quarter portfolio value change:

-2.79%
quarter

Amicus Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -3K $10.44 10K
Q2 2022 share Decrease -3.92% -408 shares 8K $10.74 10K
Q1 2022 share Increase 0.00% 10.40K shares 99K $9.47 10.40K